Evidence map›Paper›PMID 33859194›Full record

ArticleNature communications2021

Production of itaconic acid from alkali pretreated lignin by dynamic two stage bioconversion.

Joshua R Elmore, Gara N Dexter, Davinia Salvachúa, Jessica Martinez-Baird, E Anne Hatmaker, Jay D Huenemann, Dawn M Klingeman, George L Peabody, Darren J Peterson, Christine Singer and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Multi-layered metabolic remodeling ofMetabolic engineering communications · 2026
    Article
  5. Review
  6. An Efficient COAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Review
  8. Obtaining PDC and other high-added value products from lignin byJournal of integrative bioinformatics · 2025
    Article
  9. High enzyme promiscuity in lignin degradation mechanisms inApplied and environmental microbiology · 2025
    Article
  10. Advancing lignocellulosic conversion though biosensor-enabled metabolic engineering.Green chemistry : an international journal and green chemistry resource : GC · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. ReprogrammingScience advances · 2024
    Article
  17. Bacterial transformation of lignin: key enzymes and high-value products.Biotechnology for biofuels and bioproducts · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Joshua R ElmoreBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA.ORCID http://orcid.org/0000-0003-4750-9640
Gara N DexterBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA.
Davinia SalvachúaNational Bioenergy Center, National Renewable Energy Laboratory, Golden, CO, USA.
Jessica Martinez-BairdBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA.
E Anne HatmakerBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA.ORCID http://orcid.org/0000-0002-7821-8160
Jay D HuenemannBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA.
Dawn M KlingemanBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA.
George L PeabodyBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA.
Darren J PetersonNational Bioenergy Center, National Renewable Energy Laboratory, Golden, CO, USA.
Christine SingerNational Bioenergy Center, National Renewable Energy Laboratory, Golden, CO, USA.
Gregg T BeckhamNational Bioenergy Center, National Renewable Energy Laboratory, Golden, CO, USA.ORCID http://orcid.org/0000-0002-3480-212X
Adam M GussBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA. gussam@ornl.gov.ORCID http://orcid.org/0000-0001-5823-5329
Oak Ridge National Laboratory · USNational Laboratory of the Rockies · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expanding the portfolio of products that can be made from lignin will be critical to enabling a viable bio-based economy. Here, we engineer Pseudomonas putida for high-yield production of the tricarboxylic acid cycle-derived building block chemical, itaconic acid, from model aromatic compounds and aromatics derived from lignin. We develop a nitrogen starvation-detecting biosensor for dynamic two-stage bioproduction in which itaconic acid is produced during a non-growth associated production phase. Through the use of two distinct itaconic acid production pathways, the tuning of TCA cycle gene expression, deletion of competing pathways, and dynamic regulation, we achieve an overall maximum yield of 56% (mol/mol) and titer of 1.3 g/L from p-coumarate, and 1.4 g/L titer from monomeric aromatic compounds produced from alkali-treated lignin. This work illustrates a proof-of-principle that using dynamic metabolic control to reroute carbon after it enters central metabolism enables production of valuable chemicals from lignin at high yields by relieving the burden of constitutively expressing toxic heterologous pathways.

Indexed as

AlkaliesBacterial ProteinsBasidiomycotaBiosensing TechniquesBurkholderiaCarbonCitric Acid CycleCoumaric AcidsFungal ProteinsIndustrial MicrobiologyLigninMetabolic EngineeringProof of Concept StudyPseudomonas putidaSuccinatesAlkaliesBacterial ProteinsCarbonCoumaric AcidsFungal Proteinsitaconic acidLigninp-coumaric acidSuccinates

Identifiers

PMID33859194
PMCPMC8050072
OpenAlexW3153438172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.